Journal ArticleNeurology · January 4, 2011
BACKGROUND: Patient registries are valuable because they provide data that cannot be captured in any other way. Observations from registry studies are particularly informative if multiple registries confirm similar findings. A selection of multiple scleros ...
Full textLink to itemCite
Journal ArticleNeurology · January 4, 2011
BACKGROUND: Multiple sclerosis (MS) registries can provide valuable insights into the natural history of MS. Key observational findings of the registries include MS patient disability progression rate, predictors of increased disability, and changes in lif ...
Full textLink to itemCite
Journal ArticleAJNR Am J Neuroradiol · June 2010
MR imaging is widely used for the diagnosis and monitoring of patients with MS. Applications and protocols for MR imaging continue to evolve, prompting a need for continual reassessments of the optimal use of this technique in clinical practice. This artic ...
Full textLink to itemCite
Journal ArticleAnn Indian Acad Neurol · October 2009
The diagnosis of multiple sclerosis (MS) requires objective findings referable to the central nervous system. A wide differential diagnosis often has to be considered. Magnetic resonance imaging and electrophysiologic and cerebrospinal fluid studies can al ...
Full textLink to itemCite
Journal ArticleMultiple Sclerosis · April 27, 2009
Background: Initiation of immunomodulators in patients experiencing a clinically isolated syndrome (CIS) may delay progression to clinically definite MS. However, lack of consensus remains on many issues affecting optimal management of MS. Method: A panel ...
Full textCite
Journal ArticleJ Neurol Sci · September 15, 2008
Interferon (IFN) beta treatment of relapsing-remitting multiple sclerosis (RRMS) stimulates production of neutralizing antibodies (NAbs) in some patients. However, clinical data supporting the hypothesis that NAbs to IFN beta adversely affect patient outco ...
Full textLink to itemCite
Journal ArticleClin Ther · June 2008
BACKGROUND: It is not known whether the currently available treatment regimen of interferon beta-1b (IFNbeta-1b) 250 microg provides the maximum benefit possible in the treatment of relapsing-remitting multiple sclerosis (RRMS), or whether higher doses of ...
Full textLink to itemCite
Journal ArticleJournal of International Medical Research · January 1, 2007
The clinical impact of neutralizing antibodies (NAbs) on interferon beta (IFNβ) efficacy was studied in three large patient cohorts comprising 6698 multiple sclerosis (MS) patients receiving IFNβ-1b across North America, Europe, and Australia. In North Ame ...
Full textCite
Journal ArticleMult Scler · October 2005
Injection site reactions (ISRs) are a common side effect of subcutaneous interferon beta therapy, particularly during initiation of therapy. Retrospective analysis of two clinical trials showed that patients using an autoinjector experienced fewer ISRs tha ...
Full textLink to itemCite
Journal ArticleJ Neurol · January 2005
The EVIDENCE study was a direct comparative study of two dose regimens of interferon (IFN) beta-1a used in the treatment of relapsing-remitting multiple sclerosis (RRMS): 30 mcg intramuscularly once weekly (qw; n=338) and 44 mcg subcutaneously three times ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · December 1994
Inadequate cerebral oxygenation during cardiopulmonary bypass may lead to postoperative cognitive dysfunction in patients undergoing cardiac operations. A psychological test battery was administered to 255 patients before cardiac operation and just before ...
Full textLink to itemCite
Journal ArticleCirculation · November 1994
BACKGROUND: Age is a predictor of cognitive dysfunction after cardiac surgery, but the mechanism is unknown. The purpose of our study was to determine whether age-related decrements in cognition are associated with cerebral blood flow (CBF) autoregulation ...
Link to itemCite
Journal ArticleCirculation · November 1, 1994
Background: Age is a predictor of cognitive dysfunction after cardiac surgery, but the mechanism is unknown. The purpose of our study was to determine whether age-related decrements in cognition are associated with cerebral blood flow (CBF) autoregulation ...
Cite
Journal ArticleNeurology · March 1991
Previously reported serologic and polymerase chain reaction (PCR)-based findings have suggested an association between the human retrovirus, HTLV-I, and multiple sclerosis (MS). Due to the inherent ability of PCR to produce false-positive results, we devel ...
Full textLink to itemCite
Journal ArticleAnn Neurol · June 1990
Patients with clinically definite multiple sclerosis, mild to moderately severe neurological disability (entry score on the Expanded Disability Status Scale (EDSS) between 3.0 and 7.0), and a progressive course defined by an increase in the EDSS of between ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · April 1989
Twenty-one patients with multiple sclerosis, chronic progressive type, were examined for DNA sequences homologous to a human retrovirus. Genomic DNA from peripheral blood mononuclear cells was analyzed for the presence of homologous sequences to the human ...
Full textLink to itemCite
Journal ArticleJAMA · June 17, 1988
Studies in the past have reported an increased risk of exacerbations in multiple sclerosis during the postpartum period; it is not known whether breast-feeding alters this risk. We interviewed 435 women regarding pregnancy and breast-feeding history, provi ...
Link to itemCite
Journal ArticleAnn Neurol · October 1987
High-field strength (1.5 Tesla) magnetic resonance imaging in 15 patients with multiple and extensive white-matter lesions and clinically definite multiple sclerosis delineated a previously undescribed finding of abnormally decreased signal intensity on T2 ...
Full textLink to itemCite
Journal ArticleNeurology · June 1987
Follow-up observations were made of 92 white patients with early-onset Alzheimer's disease to determine the demographic, clinical, and neuropsychological factors predictive of institutionalization or death. The cumulative mortality rate 5 years after entry ...
Full textLink to itemCite
Journal ArticleAmerican Journal of Roentgenology · January 1, 1987
High-field-strength (1.5-T) MR imaging was used to evaluate 47 patients with definite multiple sclerosis and 42 neurologically normal control patients. Abnormal, multiple foci of increased signal intensity on T2-weighted images, most prominent in the periv ...
Full textCite
Journal ArticleAmerican Journal of Neuroradiology · January 1, 1987
High-field-strength (1.5-T) MR imaging was used to evaluate 47 patients with definite multiple sclerosis and 42 neurologically normal control patients. Abnormal, multiple foci of increased signal intensity on T2-weighted images, most prominent in the periv ...
Cite
Journal ArticleStroke · 1987
Patient records in 36 consecutively identified patients with typical echocardiographic findings of atrial septal aneurysm were reviewed. Ten of the 36 (28%) had cerebrovascular events. Of these 10, 5 had completed strokes of definite embolic origin on the ...
Full textLink to itemCite
Journal ArticleAnn Neurol · December 1985
We compared the clinical associations, arteriographic findings, and long-term outcome of 93 patients with amaurosis fugax and 212 patients with focal cerebral ischemia (transient ischemic attacks [TIAs]). The group of patients with cerebral TIAs included a ...
Full textLink to itemCite
Journal ArticleNeurology · May 1984
A prospective study was made of the morbidity and mortality from ischemic heart disease in 390 patients with focal TIA caused by atherosclerotic vascular disease. The 5-year cumulative rate of myocardial infarction or sudden death in these patients was 21. ...
Full textLink to itemCite
Journal ArticleAnn Neurol · January 1984
An acute Guillain-Barré syndrome presenting as dysautonomia is described in a 12-year-old boy. The patient died of intractable cardiac arrhythmias and cardiac failure. A severe myocarditis with destruction of dorsal root ganglion cells and wallerian degene ...
Full textLink to itemCite
Journal ArticleAnn Neurol · November 1983
Genetic aspects and associated clinical disorders were studied in a consecutive series of 68 men and women in whom Alzheimer's disease appeared at or before age 70. Secondary cases of dementia were found in 17 (25%) of the families, affecting 22 of the pro ...
Full textLink to itemCite
Journal ArticleJ Neurol Sci · January 1982
The following report describes a 57-year-old man with celiac disease who developed a progressive and fatal neurologic disorder despite intensive medical and nutritional care. The clinical and pathological CNS findings in this patient are compared with thos ...
Full textLink to itemCite
Journal ArticleAnn Neurol · March 1981
Seven patients with severe progressive impairment of kinesthetic sense, mild dysfunction of cutaneous sense, and sparing of motor function were examined during a 3-year period. The clinical and electrophysiological findings are described in detail. None of ...
Full textLink to itemCite
Journal ArticleNeurology · July 1977
Oral glycerol was administered to eight patients with meningeal carcinomatosis or acute leukemia in whom ventricular catheters and Ommaya reservoirs had been implanted for the purpose of intrathecal chemotherapy or chemoprophylaxis. Intraventricular pressu ...
Full textLink to itemCite